Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Review ArticleReview Article

Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges

Annika Højrup Runegaard, Ciarán Martin Fitzpatrick, David Paul Drucker Woldbye, Jesper Tobias Andreasen, Andreas Toft Sørensen and Ulrik Gether
Lynette C. Daws, ASSOCIATE EDITOR
Pharmacological Reviews April 2019, 71 (2) 123-156; DOI: https://doi.org/10.1124/pr.117.013995
Annika Højrup Runegaard
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ciarán Martin Fitzpatrick
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Paul Drucker Woldbye
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jesper Tobias Andreasen
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Toft Sørensen
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrik Gether
Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynette C. Daws
Roles: ASSOCIATE EDITOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 71 no. 2 123-156
DOI 
https://doi.org/10.1124/pr.117.013995
PubMed 
30814274

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0031-6997
Online ISSN 
1521-0081
History 
  • Published online February 27, 2019.

Copyright & Usage 
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Annika Højrup Runegaard,
  2. Ciarán Martin Fitzpatrick,
  3. David Paul Drucker Woldbye,
  4. Jesper Tobias Andreasen,
  5. Andreas Toft Sørensen, and
  6. Ulrik Gether
  1. Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience (A.H.R., D.P.D.W., A.T.S., U.G.) and Department of Drug Design and Pharmacology (C.M.F., J.T.A.), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  1. Lynette C. Daws, ASSOCIATE EDITOR
  1. Address correspondence to:
    Ulrik Gether, Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, University of Copenhagen, Mærsk Tower 5th floor, 3 Blegdamsvej, DK-2200, Copenhagen, Denmark. E-mail: gether{at}sund.ku.dk; or Andreas Toft Sørensen, Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, University of Copenhagen, Mærsk Tower 5th floor, 3 Blegdamsvej, DK-2200, Copenhagen, Denmark. E-mail: andreass{at}sund.ku.dk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: February 2019 to March 2021

AbstractFullPdf
Feb 20191712724
Mar 20191439266153
Apr 201959914473
May 201947713450
Jun 20194199644
Jul 20192405038
Aug 20192525537
Sep 20191805747
Oct 20191994747
Nov 20192044225
Dec 20191622812
Jan 20201923220
Feb 20201273225
Mar 2020137254
Apr 20201111071
May 2020712047
Jun 20201311555
Jul 202088442
Aug 2020179456
Sep 20201711476
Oct 2020178656
Nov 2020279091
Dec 20201614037
Jan 2021127043
Feb 202186652
Mar 20212157

PreviousNext
Back to top

In this issue

Pharmacological Reviews: 71 (2)
Pharmacological Reviews
Vol. 71, Issue 2
1 Apr 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Modulating Dopamine Signaling and Behavior with Chemogenetics: Concepts, Progress, and Challenges
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Review ArticleReview Article

Modulating Dopamine Signaling and Behavior with Chemogenetics

Annika Højrup Runegaard, Ciarán Martin Fitzpatrick, David Paul Drucker Woldbye, Jesper Tobias Andreasen, Andreas Toft Sørensen and Ulrik Gether
Pharmacological Reviews April 1, 2019, 71 (2) 123-156; DOI: https://doi.org/10.1124/pr.117.013995

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Review ArticleReview Article

Modulating Dopamine Signaling and Behavior with Chemogenetics

Annika Højrup Runegaard, Ciarán Martin Fitzpatrick, David Paul Drucker Woldbye, Jesper Tobias Andreasen, Andreas Toft Sørensen and Ulrik Gether
Pharmacological Reviews April 1, 2019, 71 (2) 123-156; DOI: https://doi.org/10.1124/pr.117.013995
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • I. Introduction
    • II. Chemogenetic Approaches for Dissecting Dopamine-Mediated Behaviors
    • III. Discussion and Future Directions
    • IV. Conclusion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Sex-Based Pharmacology
  • Pharmacology of Polymyxins
  • Ontogeny of Hepatic Transport and Drug Metabolism
Show more Review Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics